http://www.sciencemag.org/content/vol296/issue5576/news-summaries.shtml
Wayne Kondro
OTTAWA, CANADA--Amgen has decided to sever its ties to the University of Toronto-based research institute it has funded for nearly a decade. But in an unusual twist, it's going to continue paying millions of dollars a year for work to which the university will hold all intellectual property rights.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.